News Release

2010.10.05
FY02/2011 Q2 Results Earnings Release Presentation
2010.10.01
Noven Pharmaceuticals, Inc. press release : Noven completes acquisition of Daytrana® methylphenidate transdermal system (CII) from Shire
2010.08.27
Conduct ofAdditional Clinical Study of KW-2246, a Cancer Pain Drug
2010.08.11
Noven Pharmaceuticals, Inc. press release : Noven to acquire Daytrana® methylphenidate transdermal system from Shire
2010.06.30
FY02/2011 Q1 Results Earnings Release Presentation
2010.06.14
Financial Support to SAGA Heavy Ion Medical Accelerator in Tosu Project
2010.06.11
Announcement of Listing of “FENTOS® TAPE,” a transdermal, long-acting cancer pain relief patch, on the NHI Drug Price Standard
2010.05.26
Notice of Application for Delisting of Stock on Osaka Stock Exchange
2010.05.26
Notice of Personnel Changes
2010.04.23
Results of Phase III Clinical Trial of HKT-500 in the USA
2010.04.16
Hisamitsu Pharmaceutical Announces Marketing Approval of FENTOS® TAPE (Development Code: HFT-290), Transdermal, Long-Acting Cancer Pain Relief Patch
2010.04.08
FY02/2010 Q4 Results Earnings Release Presentation
2010.03.25
Hisamitsu Announces U.S. Launch of its “Fentanyl Transdermal System” for the Management of Chronic Pain
2010.03.24
Revision of Earnings Forecast
2010.02.25
Application Filed for Cancer Pain Drug (KW-2246)
2010.02.01
Kyowa Hakko Kirin and Hisamitsu entered into a Joint Distribution Agreement on Cancer Pain Drug (Development Code: KW-2246)
2010.01.08
FY02/2010 Q3 Results Earnings Release Presentation

PAGETOP